- [INMUNOLOGÍA E INMUNOTERAPIA]
- [ESTRATEGIAS COMBINADAS DE INMUNOTERAPIA TRASLACIONAL]
- [TERAPIAS BASADAS EN CITOQUINAS]
Human CD8 T cells are susceptible to TNF-mediated activation-induced cell death
Otano I (1,2), Alvarez M (1,2), Minute L (1,2), Ochoa MC (1,2,3,4), Migueliz I (2,4), Molina C (1,2), Azpilikueta A (1,2), de Andrea CE (2,3,5,6), Etxeberria I (1,2), Sanmamed MF (1,2,7), Teijeira Á (1,2,3), Berraondo P (1,2,3), Melero I (1,2,3,7,4).
Activation-induced cell death (AICD) is a complex immunoregulatory mechanism that causes the demise of a fraction of T-lymphocytes upon antigen-driven activation. In the present study we investigated the direct role of TNF in AICD of CD8 T lymphocytes.
Methods: Human peripheral mononuclear cells were isolated from healthy donors and fresh tumor-infiltrating lymphocytes were obtained from cancer patients undergoing surgery. T cells were activated with anti-CD3/CD28 mAbs or with a pool of virus peptides, in combination with clinical-grade TNF blocking agents.
Results: A portion of CD8 T cells undergoes apoptosis upon CD3/CD28 activation in a manner that is partially prevented by the clinically used anti-TNF agents infliximab and etanercept. TNF-mediated AICD was also observed upon activation of virus-specific CD8 T cells and tumor-infiltrating CD8 T lymphocytes. The mechanism of TNF-driven T cell death involves TNFR2 and production of mitochondrial oxygen free radicals which damage DNA.
Conclusion: The use of TNF blocking agents reduces oxidative stress, hyperpolarization of mitochondria, and the generation of DNA damage in CD8 T celss undergoing activation. The fact that TNF mediates AICD in human tumor-reactive CD8 T cells suggests that the use of TNF-blocking agents can be exploited in immunotherapy strategies.
CITA DEL ARTÍCULO Theranostics. 2020 Mar 15;10(10):4481-4489. doi: 10.7150/thno.41646. eCollection 2020